Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 449 followers

Latest posts

Last updated 1 minute ago

Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 18, Status: Authorised

8 minutes ago

Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation...

Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation: 25/06/2025, Revision: 4, Status: Authorised

12 minutes ago

Human medicines European public assessment report (EPAR): Vevzuo, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised

22 minutes ago

Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation: 26/02/2025, Revision: 2, Status: Authorised

about 1 hour ago

Human medicines European public assessment report (EPAR): Paxneury, guanfacine, Date of authorisation...

Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 11, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation...

Plasma master file timetable: 30-day - Period 2026-2028

about 7 hours ago

Plasma master file timetable: 30-day - Period 2026-2028

Plasma master file timetable: 60-day - Period 2026-2028

about 7 hours ago

Plasma master file timetable: 60-day - Period 2026-2028

Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation: 06/03/2009, Revision: 23, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Mepact, mifamurtide, Date of authorisation...

Scientific publications

1 day ago

Scientific publications

Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation: 05/09/2013, Revision: 19, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Procysbi, mercaptamine, Date of authorisation...

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation: 20/06/2024, Revision: 10, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Wezenla, ustekinumab, Date of authorisation...